Click here for an analysis of Cartesian Therapeutics' recent stock rebound and RNA cell therapy assets, including mixed ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today a positive opinion has been received from the Committee for Medicinal Products for Human Use (CHMP) of ...

Activities of Daily Living We are likely to see meaningful ... Many frauds that target seniors are designed to look like a bill. Other forms of fraud make promises of long-term benefits that ...

-- It would cover a maximum of 20 hours of paid care per week, based on the statement in the campaign's fact sheet that "the vast majority of seniors with long-term care needs are still able to live ...

After dosing with Cognition’s CT1812, study reports declines of 95% and higher in subgroup with below-median p-tau217.

Cognition Therapeutics, Inc., (the "Company” or "Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, presented participant baseline ...

Naar’s decision to step down meant he wasn’t privy to one of the task force’s more contentious recommendations: that the university “immediately” form a committee to review ... groups like StandWithUs ...

There are also some communities that provide specialty care, called memory care, designed for those with Alzheimer’s disease or other forms of dementia ... during the assessment process include: — ...

Cassava Sciences, Inc. ( NASDAQ: SAVA) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Rick Barry - President & Chief Executive Officer Eric Schoen - Chief Financial Officer ...

MSA patients experienced higher baseline symptom burden, and reduced activities of daily living and quality of life ... of the study is change in the Orthostatic Hypotension Symptom Assessment (OHSA) ...